Drug Pipeline

Brigatinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
3
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04374305 Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related… Neurofibromatosis Type 2 Recruiting
NCT04223596 Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients Lung Cancer Active, Not Recruiting
NCT04318938 Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping NSCLC Active, Not Recruiting
Not specified
NCT05100069 Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer Non-small Cell Lung Cancer (NSCLC) Recruiting
NCT05721950 A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants… Non-small Cell Lung Cancer (NSCLC) Active, Not Recruiting
Sponsors Running Brigatinib Trials
Disease Areas
Get alerts when Brigatinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free